Arterra Bioscience
ARBS.MI · MIL
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €16,114 | €13,051 | €15,181 | €11,053 |
| - Cash | €3,442 | €3,343 | €3,427 | €3,686 |
| + Debt | €308 | €356 | €343 | €386 |
| Enterprise Value | €12,980 | €10,064 | €12,097 | €7,754 |
| Revenue | €2,572 | €1,922 | €2,560 | €1,085 |
| % Growth | 33.8% | -24.9% | 136% | – |
| Gross Profit | €477 | €390 | €1,408 | €619 |
| % Margin | 18.6% | 20.3% | 55% | 57.1% |
| EBITDA | €1,226 | €1,249 | €593 | €1,222 |
| % Margin | 47.7% | 65% | 23.2% | 112.6% |
| Net Income | €1,085 | €819 | €517 | €828 |
| % Margin | 42.2% | 42.6% | 20.2% | 76.3% |
| EPS Diluted | 0.16 | 0.12 | 0.078 | 0.12 |
| % Growth | 33.3% | 54.4% | -35.2% | – |
| Operating Cash Flow | €1,529 | €372 | €692 | €513 |
| Capital Expenditures | -€384 | -€474 | -€166 | -€41 |
| Free Cash Flow | €1,145 | -€103 | €526 | €472 |